Literature DB >> 30040511

Gene therapy in inherited retinal degenerative diseases, a review.

Vitor K L Takahashi1,2,3, Júlia T Takiuti1,2,4, Ruben Jauregui1,2,5, Stephen H Tsang1,2,6.   

Abstract

Hereditary diseases of the retina represent a group of diseases with several heterogeneous mutations that have the common end result of progressive photoreceptor death leading to blindness. Retinal degenerations encompass multifactorial diseases such as age-related macular degeneration, Leber congenital amaurosis, Stargardt disease, and retinitis pigmentosa. Although there is currently no cure for degenerative retinal diseases, ophthalmology has been at the forefront of the development of gene therapy, which offers hope for the treatment of these conditions. This article will explore an overview of the clinical trials of gene supplementation therapy for retinal diseases that are underway or planned for the near future.

Entities:  

Keywords:  Adeno-associated virus; gene therapy; inherited retinal diseases

Mesh:

Year:  2018        PMID: 30040511     DOI: 10.1080/13816810.2018.1495745

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  24 in total

Review 1.  Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques.

Authors:  Galaxy Y Cho; Kyle Bolo; Karen Sophia Park; Jesse D Sengillo; Stephen H Tsang
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

2.  Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.

Authors:  Ruben Jauregui; Karen Sophia Park; Akemi J Tanaka; Ahra Cho; Maarjaliis Paavo; Jana Zernant; Jasmine H Francis; Rando Allikmets; Janet R Sparrow; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2019-06-08       Impact factor: 5.258

3.  Choriocapillaris flow loss in center-involving retinitis pigmentosa: a quantitative optical coherence tomography angiography study using a novel classification system.

Authors:  Sally S Ong; T Y Alvin Liu; Ximin Li; Mandeep S Singh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-05-31       Impact factor: 3.117

Review 4.  Stem cell transplantation as a progressing treatment for retinitis pigmentosa.

Authors:  Sedighe Hosseini Shabanan; Homa Seyedmirzaei; Alona Barnea; Sara Hanaei; Nima Rezaei
Journal:  Cell Tissue Res       Date:  2022-01-10       Impact factor: 5.249

5.  Targeted next-generation sequencing identifies ABCA4 mutations in Chinese families with childhood-onset and adult-onset Stargardt disease.

Authors:  Ling-Hui Qu; Xin Jin; Chao Zeng; Nian-Gou Zhou; Yan-Hong Liu; Ye Lin
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 6.  Impact of Photoreceptor Loss on Retinal Circuitry.

Authors:  Joo Yeun Lee; Rachel A Care; Luca Della Santina; Felice A Dunn
Journal:  Annu Rev Vis Sci       Date:  2021-09-15       Impact factor: 6.422

Review 7.  CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.

Authors:  Seyed Ahmad Rasoulinejad; Faezeh Maroufi
Journal:  Mol Biotechnol       Date:  2021-05-31       Impact factor: 2.695

8.  Differences in Intraretinal Pigment Migration Across Inherited Retinal Dystrophies.

Authors:  Jin Kyun Oh; Sarah R Levi; Joonpyo Kim; Jose Ronaldo Lima de Carvalho; Joseph Ryu; Janet R Sparrow; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2020-05-20       Impact factor: 5.488

9.  PKM2 ablation enhanced retinal function and survival in a preclinical model of retinitis pigmentosa.

Authors:  Ethan Zhang; Joseph Ryu; Sarah R Levi; Jin Kyun Oh; Chun Wei Hsu; Xuan Cui; Ting-Ting Lee; Nan-Kai Wang; Jose Ronaldo Lima de Carvalho; Stephen H Tsang
Journal:  Mamm Genome       Date:  2020-04-27       Impact factor: 3.224

10.  Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology.

Authors:  Ayub Qassim; Emmanuelle Souzeau; Georgie Hollitt; Mark M Hassall; Owen M Siggs; Jamie E Craig
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.